✦ LIBER ✦

TCT-47 Two-Year Clinical Outcome of the TWENTE Trial, a Randomized Controlled Trial Comparing Second-Generation Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in Real-World Patients

✍ Scribed by Clemens von Birgelen; Kenneth Tandjung; Hanim Sen; Mounir Basalus; J. Hans Louwerenburg; Martin Stoel; K. Gert van Houwelingen; Gerard Linssen; Salah Saïd; Mark Nienhuis; Marije Löwik; Job van der Palen; Patrick Verhorst; Frits de Man

Book ID: 119272121
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 117 KB
Volume: 60
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2012.08.056

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of Lesion Length and Vessel Size

Impact of Lesion Length and Vessel Size on Clinical Outcomes After Percutaneous Coronary Intervention With Everolimus- Versus Paclitaxel-Eluting Stents: Pooled Analysis From the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials

✍ Bimmer E. Claessen; Pieter C. Smits; Dean J. Kereiakes; Helen Parise; Martin Fah 📂 Article 📅 2011 🏛 American College of Cardiology 🌐 English ⚖ 503 KB

TCT-214: Safety and Effectiveness of Eve

TCT-214: Safety and Effectiveness of Everolimus-Eluting Stents in 5054 Patients from a Large, Prospective, Real World Study: Two-Year Clinical Outcomes from the XIENCE V® USA Study

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 115 KB

TCT-255: Consistent Efficacy and Safety

TCT-255: Consistent Efficacy and Safety of Everolimus-Eluting Stents In 5054 Patients From a Large Prospective Real World Study: One-Year Clinical Outcomes From the XIENCE V® USA Study

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 92 KB